KBW Ventures Invests In Singapore-Based Biotech Startup TurtleTree Labs
Summary
TurtleTree is the worlds first company using technology to create real milk from animal cells, with no animal required KBW Ventures, founded by HRH Prince Khaled bin Alwaleed bin Talal Al Saud, has taken part in a pre-seed funding round for Singapore-based startup, TurtleTree Labs. Co-founded by CEO Fengru Lin, Chief Scientist Officer Rabail Toor, and Chief Strategist Max Rye, TurtleTree Labs has developed a unique proprietary technology that uses mammary cells to produce real, full milk in clean food production facilities. The end product allows for not just the full functionality of dairy milk, but is also expected to disrupt the existing baby formula industry. “This is long-term investment; we’re not in this for the quick win,” HRH Prince Khaled bin Alwaleed bin Talal Al Saud told Entrepreneur, noting that investing in the development of alternative protein sources that use less natural resources by biotech startups is one way to play a role in solving “what is truly the most pressing issue of our times: the climate crisis.” According to Rye, the seed funding will be used to further build out the company’s scientific team and to create additional prototypes. The technology that TurtleTree is working with is proprietary, so much of the value of biotech and food tech companies is found in their technology-based answers to seemingly futuristic needs.